<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Parvovirus B19 DNA was detected in serum samples from 10 out of 42 patients with <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0001903'>anaemia</z:hpo>, the majority of whom suffered from aplastic <z:hpo ids='HP_0001903'>anaemia</z:hpo>, <z:hpo ids='HP_0001878'>haemolytic anaemia</z:hpo>, pure red cell <z:hpo ids='HP_0001903'>anaemia</z:hpo> or <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Nested PCR methods with sensitivities of 0.005-0.05 fg DNA were developed </plain></SENT>
<SENT sid="2" pm="."><plain>In nine patients, B19 DNA could only be detected by nested PCR </plain></SENT>
<SENT sid="3" pm="."><plain>Conventional PCR with a sensitivity of 50 fg B19 DNA could only detect B19 DNA in one patient </plain></SENT>
<SENT sid="4" pm="."><plain>In the majority of B19-DNA-positive patients, the DNA concentration was estimated at 0.005-0.05 fg per 5 microliters serum </plain></SENT>
</text></document>